GlucoTech
Diabetes has reached epidemic proportions globally. In order for diabetics to remain healthy, close monitoring and adjustment of sugar, or glucose, levels is vital. Scientists have long been searching for technologies capable of accurately, and continuously, measuring sugar levels without frequent and painful finger pricks. GlucoTech offers an innovative new implant solution that may totally redefine diabetes care.
WHY GLUCOTECH?
Pain-Free
Physicians recommend that diabetic patients maintain strict control of their sugar levels, which requires drawing blood and measuring sugar with a glucose meter. Not only is this inconvenient, but it can also be painful. There are some alternatives that do not require finger pricks, but to ensure accuracy they all require daily calibrations with blood.
Integrated
When people with diabetes use a blood glucose meter, the results represent a snapshot in time, making it difficult to easily monitor trends in sugar levels. Currently, individuals must keep detailed time- and labor-intensive data logs to have any hope of learning personal trends and gaining control over their illness.
Automatic
While measuring sugar levels is vital, having to draw blood multiple times a day is painful, inconvenient, embarrassing, and easy to forget. As a result, only 61% of people with Type I diabetes monitor their blood sugar even once daily. A staggering 95% of Type II diabetics fail to check their sugar once a day.
Life Saving
When sugar levels fluctuate, diabetic individuals must act quickly to avoid serious medical complications. But, sugar can spike or fall to dangerous levels in between manual tests. Nearly 75% of potentially fatal low blood sugar episodes occur at night when people are less likely to monitor their glucose. Fully 6% of deaths in young diabetics are thought to be due to low blood sugar.
The glucotech Solution
Forget needles. GlucoTech’s patented implant technology may make it possible to continuously and automatically monitor glucose levels without drawing any blood. GlucoTech may just make those pesky needles and lancets a thing of the past.
GlucoTech is a continuous glucose monitoring device that wirelessly sends glucose readings to a smart-enabled device, creating automated and accurate records. These continuous, daily records of sugar levels may help people with diabetes make healthy choices without the headache of manual logs.
The GlucoTech device is permanently embedded and will require virtually no patient participation. GlucoTech’s implant is designed to automatically measure glucose levels, sending detailed information and safety alerts to a smart-enabled device. No pain, no embarrassment, no forgetting – just automatic information.
GlucoTech offers continuous and effortless glucose monitoring, both day and night. If glucose levels fluctuate outside of the safe range, users and their healthcare providers can be alerted immediately through any smart- enabled device. An immediate response is vital to saving lives.
GlucoTech redefines Diabetes Care
GlucoTech offers an innovative means of accurately and continuously monitoring glucose levels via a wireless, discrete, and easily maintained implant. Using GlucoTech’s patented technology, individuals with diabetes should be able to easily keep track of their glucose levels through an automated and pain-free system that can be easily accessed through any smart-enabled device. GlucoTech has the potential to revolutionize diabetes management.
Frequent and accurate monitoring of glucose levels is an essential part of proper diabetes care and can help people with diabetes maintain control over their sugar levels. In turn, careful monitoring minimizes potentially serious medical complications and allows people with diabetes to live a long and healthy life.
Scientists have been working tirelessly to develop improved glucose monitoring technologies. One of the most coveted advances is continuous glucose monitoring (CGM). Often called the ‘Holy Grail’, CGM offers automatic tracking of sugar levels with the goal of reducing the reliance on painful finger pricks. Potential CGM solutions range from tattoos to contact lenses to under the skin implants. They are in various stages of development and have yielded variable results. However, not only are these systems less accurate than traditional blood glucose meters, they require frequent replacement, which is expensive and inconvenient, and may even be painful.
Combining innovative glucose sensing technology with unique sensor placement, GlucoTech just may offer the solution companies and researchers the world over have been clamoring for. Contact us to find out how.
The Worldwide Diabetes Epidemic
The prevalence of diabetes around the world has reached epidemic proportions. Advances in the prevention, monitoring and treatment of diabetes are essential. According to the World Health Organization and the Centers for Disease Control:
347 Million
people worldwide have diabetes
diabetes increases the risk of:
kidney failure
heart disease
stroke
blindness
neuropathy
amputations
in the USA 1 out of 3 people will develop type II diabetes in their lifetime
diabetes related deaths are projected to double from 2005-2030
making diabetes the 7th leading cause of death worldwide by 2030
7th
Market Potential
Diabetes related medical expenses cost the United States $245 billion in 2012. This spending was in no small part due to the sale of blood glucose monitoring systems, which are projected to represent a $12.2 billion market by 2017. GlucoTech offers a range of solutions that will impact the healthcare and glucose monitoring industries.
Click on the icons below to reveal GlucoTech’s potential.
Continuous Glucose Monitoring
Continuous Glucose Monitoring (CGM) is an area of active research with a significant market share. Allied Market Research reports that in 2012 the continuous glucometer market was valued at $194.8 million; they estimate that it will reach $568.5 million by 2020. Currently, FDA approved CGM systems monitor skin glucose levels using small implants that are placed under the skin. While the sugar levels they measure correlate strongly with blood glucose levels, these CGM systems are no substitute for the time-tested finger stick. In fact, these systems are meant to compliment, not replace, conventional blood glucose meters, and require a minimum of twice-daily calibrations using blood samples. Furthermore, the skin implants only last 2-7 days, necessitating invasive sensor replacement. Lastly, these systems send monitoring data to company-manufactured handheld devices that do not sync to other smart-enabled mobile devices, which is inconvenient to say the least.
GlucoTech offers innovative solutions to these challenges. Designed for convenience and accuracy, GlucoTech offers an affordable, viable alterative to current CGM devices.
Artificial Pancreas Devices & Insulin Pumps
Today, 20% of people with Type I diabetes use an insulin pump to help regulate their glucose levels. An insulin pump is a small, computerized machine worn on the body that can administer small doses of insulin through a catheter. In order for the pump to deliver the appropriate amount of insulin, the user must frequently and manually monitor their blood glucose level. Recently, there have been some advances in development of artificial pancreas devices that both monitor and regulate insulin levels automatically in order to mimic the functions of a healthy pancreas, but much more work is needed. Automated insulin delivery systems represent a growing market projected to reach $13.8 billion by 2019 at a compound annual growth rate of 7%.
GlucoTech is currently developing an insulin delivery system to compliment its glucose monitoring implant.
Additional Markets
Obesity is a major issue plaguing an ever-growing number of people. In the United States, currently two thirds of the population is overweight, while one third is classified as obese. Diabetes is but one health complication frequently associated with obesity. Careful monitoring of various blood glucose levels can be a useful tool in regulating weight gain, even in individuals not diagnosed with diabetes. Therefore, GlucoTech’s patented technology could be applied as a sophisticated diet aid to help those suffering from obesity. The overall U.S. weight loss market reached $60.5 billion in 2013.
People without diabetes can also suffer from acute hyperglycemia, or high blood sugar. Caused by severe trauma, these patients are frequently in critical condition. Therefore, it is vital that medical practitioners monitor sugar levels in critically ill hospital patients, a potentially labor-intensive process. GlucoTech’s technology could be used to create automated monitoring devices for hospital use.
GlucoTech is currently held by the Inovatzia, Inc. inventor as an independent company. As and when the Inovatzia team deems appropriate, Inovatzia, Inc. will purchase GlucoTech in order to license specific applications of the GlucoTech implant to relevant industries. At this point GlucoTech will operate as a subsidiary of Inovazia, Inc. generating revenue through intellectual property licensing, software licensing, fees from continued product development, and add-on products developed, patented, and provided by Inovatzia, Inc.
Interested in learning more? Inovatzia provides a range of options that fit you.
Click to contact Us for:
